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Abstract
Background Without assistance, smokers being admitted
to the hospital for coronary heart disease often return to
regular smoking within a year.
Objective This study assessed the 12-month effectiveness
of a telephone and a face-to-face counselling intervention
on smoking abstinence among cardiac patients. Differential
effects for subgroups varying in their socioeconomic status
and intention to quit smoking were also studied.
Methods A randomised controlled trial was used. During
hospital stay, smokers hospitalised for coronary heart dis-
ease were assigned to usual care (n = 245), telephone coun-
selling (n = 223) or face-to-face counselling (n = 157). Eli-
gible patients were allocated to an intervention counselling
group and received nicotine patches. After 12 months, self-
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reported continued abstinence was assessed and biochem-
ically verified in quitters. Effects on smoking abstinence
were tested using multilevel logistic regression analyses ap-
plying the intention-to-treat approach.
Results Compared with usual care, differential effects of
telephone and face-to-face counselling on continued absti-
nence were found in patients with a low socioeconomic
status and in patients with a low quit intention. For these
patients, telephone counselling increased the likelihood of
abstinence threefold (OR = 3.10, 95 % CI 1.32–7.31, p =
0.01), whereas face-to-face counselling increased this like-
lihood fivefold (OR = 5.30, 95 % CI 2.13–13.17, p < 0.001).
Considering the total sample, the interventions did not re-
sult in stronger effects than usual care.
Conclusion Post-discharge telephone and face-to-face
counselling interventions increased smoking abstinence
rates at 12 months compared with usual care among car-
diac patients of low socioeconomic status and low quit
intentions. The present study indicates that patients of
high socioeconomic status and high quit motivation require
different cessation approaches.
Keywords Coronary heart disease · Smoking cessation ·
Telephone counselling · Face-to-face counselling ·
Socioeconomic status · Intention to quit
Background
Although studies have estimated up to 40 % reduced risks
of recurrent coronary events and subsequent mortality in pa-
tients who quit smoking after a coronary event [1], one out
of two patients still persist in smoking or relapse after hos-
pital discharge [2–4]. Behavioural interventions initiated
during hospital admission with regular follow-up contacts
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Fig. 1 Flow diagram of the ex-
perimental study evaluating two
smoking cessation counselling
interventions in cardiac patients.
UC usual care, NRT nicotine
replacement therapy, in this trial
nicotine patches only given to
patients who agreed to use them
and without any contraindica-
tions indicated by the cardiolo-
gist, TC telephone counselling,
FC face-to-face counselling
8 parcipang 
cardiac wards 
Cross-over randomisaon at 
the ward level (n = 625)
Paents allocated to 
usual care 
(n = 245)
Post-measurement at 
6 monthsb (n = 170)
Paents allocated to 
telephone counselling 
+ NRT (n = 223)
Paents allocated to face-
to-face counselling 
+ NRT (n = 157)
Post-measurement at 
12 months (n = 188)
Post-measurement at 
6 monthsb (n = 196)
Post-measurement at 
6 monthsb (n = 123)
Post-measurement at 
12 months (n = 169)
Post-measurement at 
12 months (n = 112)
n = 15 refused; n = 10 
died; n = 24 not 
reacheda
n = 14 refused; n = 5 
died; n = 34 not 
reacheda
n = 15 refused; n = 2
died; n = 17 not 
reacheda
Allocaon
Follow-up
Enrolment
Received UC (quit 
advice by cardiologist 
+ brochure)
Received UC + 7 TC 
sessions for 3 months 
(+ 8 weeks NRT)
Received UC + 7 FC 
sessions for 3 months 
(+ 8 weeks NRT)
Analyses
+ n = 16 refused; + n =
1 died; n = 15 not 
reached
+ n = 20 refused; + n =
2 died; n = 13 not 
reached
+ n = 16 refused; + n =
1 died; n = 11 not 
reached
n = 234 included for 
intenon-to-treat analysis
n = 216 included for 
intenon-to-treat analysis
n = 154 included for 
intenon-to-treat analysis
a Paents who refused to parcipate and who died were excluded from further follow-up measurements; paents who were not reached 
   aer 6 months were recalled to obtain follow-up data at 12 months
b The results of the 6-month follow-up study have been published previously 
for at least one month after discharge yielded significantly
higher long-term abstinence rates than brief interventions in
hospitalised patients [5]. Studies testing such interventions
in cardiac patients also demonstrated high rates of sustained
abstinence [6–10]. Combining intensive behavioural coun-
selling with pharmacotherapy further increases effective-
ness [5, 11, 12]. Despite accumulating evidence of success
of such interventions, no studies have compared different
counselling modalities for determining which intervention
is most successful for whom. Reviews showed that tele-
phone and face-to-face counselling are similarly effective
for smokers in general, though telephone counselling is
generally less intensive than face-to-face counselling [13,
14]. Yet, these delivery methods have not yet been ex-
perimentally tested against each other. Identifying which
intervention is most effective for which patient subgroup
can provide valuable information for their implementation.
Relevant in this context are subgroups of patients that
are at higher risk of continued smoking, i. e. those with
a low socioeconomic status (SES). Socioeconomic inequal-
ities in health behaviour persist in coronary heart disease
[15]. Studies have shown that individuals with a lower
SES have a less favourable profile towards smoking than
high SES patients due to a lower self-efficacy towards non-
smoking, a less favourable social environment, less so-
cial support, and more stress and negative affect leading
to fewer successful quit attempts [16]. Moreover, smokers
with a low SES have been found to profit least from ces-
sation methods due to, among other reasons, a lack of mo-
tivation to quit [15, 17–19]. Studies therefore suggest the
need for relatively intensive interventions for these groups
[20]. In contrast, smokers with a high SES are recognised
as more successful in quitting due to a higher intention to
quit and may therefore profit sufficiently from somewhat
less intensive interventions [17].
The present study compared two different smoking ces-
sation counselling interventions initiated during hospital
admission with usual care among subgroups of cardiac
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Fig. 2 Intervention protocols of telephone counselling and face-to-face counselling. aEach telephone counselling session was designed to last
15 min and each face-to-face session 30–45 min besides the last follow-up by telephone (also 15 min). bFor telephone counselling, the themes of
sessions 5 and 6 were discussed the other way round. cMany patients are already in the action stage because they quit at hospital admission
patients in a multicentre randomised controlled trial. It
was hypothesised that face-to-face counselling increases the
proportion of patients who abstain from smoking among
low SES patients and patients with a low motivation to
quit, whereas telephone counselling would be sufficient to
reduce smoking in patients with a high SES and a high
motivation to quit 12 months after hospital discharge.
Methods
Setting and design
A randomised controlled trial with sequential cross-over
randomisation at the cardiac ward level of eight hospitals
throughout the Netherlands was used. The Medical Re-
search Ethics Committee of the VU Medical Centre Ams-
terdam and the review board of each hospital approved the
study protocol (Trial Registration: NTR2144).
Study population
From December 2009 through June 2011, ward nurses re-
cruited eligible patients at the bedside. Eligible patients
were ≥18 years of age, smoked ≥5 cigarettes per day or
had quit smoking less than 4 weeks prior to admission, and
had been admitted to the cardiac ward for less than 4 days
for an acute coronary syndrome, stable angina, or other
forms of heart disease following the International Classifi-
cation of Diseases-10 [21]. Exclusion criteria were being
unable to speak and/or read Dutch, not owning a telephone,
a medically unstable situation, and cognitive impairment.
Patients provided written informed consent. Fig. 1 presents
inclusion rates.
Interventions
Usual care
Usual care consisted of an assessment of the smoking be-
haviour, provision of advice to quit by cardiologists or
ward nurses, and delivery of a general smoking cessation
brochure.
Protocol-based interventions: telephone and face-to-face
counselling
Details of the intervention protocols have been reported
elsewhere [22]. The telephone and face-to-face counselling
intervention had an inpatient and outpatient phase. The
inpatient phase incorporated the Ask-Advise-Refer strat-
egy [23, 24] in which patients’ smoking behaviour was as-
sessed, smokers were advised to quit, and referred to outpa-
tients’ smoking cessation counselling, either by telephone
or face-to-face. Interventions started within one week of pa-
tient enrolment and had a comparable structure and content.
The counsellors tailored the counselling to the patient’s
stage in the quitting process (Fig. 2). Telephone counselling
was provided by counsellors from the Dutch Expert Centre
for Tobacco Control and lasted 15 min per call. Face-to-
face counselling was provided by cardiac nurses who, for
the purpose of the study, were qualified as smoking cessa-
tion counsellors. Face-to-face counselling lasted 30–45 min
per session. In each session, patients were counselled by
the same counsellor. The counsellors worked with a proto-
col and following each session, they completed a registra-
tion form (one per patient) on which the date, the duration,
and important remarks on the session were noted. Upon
admission, ward nurses also provided nicotine patches for
eight weeks at no cost to patients eligible for their use, as
indicated by the cardiologist.
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Data collection at baseline
At baseline nurses recorded patient data and administered
a questionnaire to patients for assessing various socio-
demographics, diagnosis and other disease-related factors,
psychosocial factors, and smoking-related factors such as
current smoking behaviour, past smoking habits, and nico-
tine dependence level [25, 26]. The psychosocial factors
assessed were levels of anxiety (α = 0.79) and depression
(α = 0.81) with the Hospital Anxiety and Depression Scale
(HADS) [27], self-efficacy towards smoking abstinence in
various situations (α = 0.93) [28], and intention to quit (α =
0.86) [29]. For assessing intention to quit, patients had to
indicate how strongly they intended to quit smoking and
how likely it was that they would refrain from smoking
after hospital discharge with answers ranging from ‘not
likely’ (1) to ‘very likely’ (5) for both items [29].
Data collection at follow-up
Outcome measurement
Outcomes after 12 months were obtained in structured tele-
phone interviews by an independent call agency, for which
patients received a reminder by post. The primary outcome
measure was continued abstinence according to the inten-
tion-to-treat scenario. To determine the duration of smoking
abstinence in those patients who reported to have quit, the
quit date indicated by patients was subtracted from the date
of the telephone interview, and this period had to be at least
240 days (accounting for the 3-month intervention duration
and some variation) to be classified as being continuously
abstinent from smoking.
Biochemical validation
Patients who indicated not smoking at 12-month follow-
up (n = 187) were invited to the hospital for biochemical
validation using the NicAlert® test strips for assessing co-
tinine in saliva specimens. Tests were conducted by nurses
in 79 patients. Eight patients completed the test at home
because they were not able to attend the hospital. The other
patients (n = 100) did not complete the test because they did
not show up in the hospital or refused to do the test. A cut-
off point of ≥2 for saliva indicated tobacco smoking [30].
In 90 % (n = 79) of all the tests the result of the NicAlert®
test was 2 and in agreement with the self-reports. For the
10 % (n = 8) in which cotinine was detected, patients were
treated as smokers.
Statistical analyses
Baseline characteristics of the three groups were compared
using ANOVAs and χ2 tests. An attrition analysis was con-
ducted using a logistic regression analysis to determine pos-
sible selective dropout at follow-up excluding patients who
died (n = 21). The χ2 tests subsequently assessed continued
abstinence rates for each group at 12-month follow-up.
The main analysis concerned a generalised linear mixed
model (GLMM) to account for correlated data structure and
possible hospital-level variation. The GLMM tested the ef-
fects of the interventions and corrected for possible con-
founding factors. Differential effects for SES and intention
to quit were also tested. Therefore, SES was dichotomised
in low versus high SES on the basis of its median score
whereas intention to quit was transformed into z-scores.
To obtain the most parsimonious model, a hierarchical top-
down elimination procedure was used removing non-signif-
icant covariates (p < 0.05) until only variables remained that
made significant contributions to the prediction of contin-
ued abstinence, plus baseline differences. When differential
effects were detected (p  0.10), GLMM analyses were re-
peated for subgroups changing the reference category in
categorical variables, or changing the value of the moder-
ator to low (z-score –1), moderate (z-score), and high (z-
score +1) in continuous variables. This was done to test
the simple effects of the interventions for the respective
subgroup. Post-hoc χ2 tests were conducted to assess the
difference in effect for the moderator analysing continued
abstinence rates for each group. Data were analysed using
the ‘intention-to-treat’ approach.
Results
As summarised in Table 1, the usual care group had sig-
nificantly lower nicotine dependence than the face-to-face
counselling group, and there was a significantly higher rate
of patients in the usual care group who had made one or
more attempts to quit over the past 12 months compared
with the telephone counselling group.
Differential effects for telephone and face-to-face
counselling on smoking abstinence at 12-month follow-
up
No difference in attrition rates was observed between the
three groups at follow-up (Fig. 1). However, there were
trends that patients were more likely to be lost to follow-
up when they had previously been admitted to the hospital
(OR = 1.62, 95 % CI 1.00–2.61, p = 0.05) and when they
had made one or more attempts to quit in the past (OR =
1.51, 95 % CI 0.98–2.33, p = 0.06).
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Table 1 Baseline characteristics of patients enrolled in the study (n = 625)a
UC (n = 245) TC (n = 223) FC (n = 157) χ²/F ratio p
Sociodemographic factors
Age; M (SD) 56.08 (10.96) 55.31 (10.53) 56.54 (10.57) 0.65 0.521
Sex (male); n (%) 183 (74.7) 163 (73.1) 111 (70.7) 0.77 0.678
Marital status; n (%)
Married with/without children 161 (67.6) 151 (68.9) 102 (66.2) 0.31 0.857
Single/divorced/widow 76 (32.1) 68 (31.1) 52 (33.8) – –
Education levelb; n (%)
Low education 99 (41.8) 84 (38.2) 64 (41.6) 2.37 0.667
Intermediate education 85 (35.9) 88 (40.0) 63 (40.9) – –
High education 53 (22.4) 48 (21.8) 27 (17.5) – –
Clinical factors
Disease diagnosis; n (%)
ACSc 212 (86.9) 192 (86.1) 131 (83.4) 5.18 0.270
Stable angina 16 (6.6) 23 (10.3) 14 (8.9) – –
Other/unspecified diagnosis 16 (6.6) 8 (3.6) 12 (7.6) – –
Previous hospital admission; n (%) 49 (20.4) 37 (16.7) 38 (24.5) 3.45 0.179
Blood pressure; M (SD)
Systolic 123.51 (19.07) 123.89 (17.88) 124.07 (16.38) 0.05 0.950
Diastolic 71.61 (11.88) 72.60 (10.86) 72.92 (10.69) 0.76 0.468
Total/HDL cholesterol ratio; M (SD) 4.80 (1.93) 4.66 (1.58) 4.73 (1.57) 0.38 0.686
Body mass index; M (SD) 26.52 (4.10) 27.09 (5.69) 26.87 (4.81) 0.76† 0.470
Cardiac rehabilitation; n (%) 105 (44.9) 99 (45.8) 58 (37.7) 8.54 0.074
Smoking-related factors
Nicotine dependenced; M (SD) 5.09 (2.34) 5.31 (2.10) 5.69 (2.00) 3.56 0.029*
Average cigarettes per day; M (SD) 19.75 (10.38) 21.13 (13.79) 22.28 (11.67) 2.17 0.116
7-day abstinence at admission; n (%) 89 (36.8) 66 (29.9) 46 (29.7) 3.28 0.194
Previous attempt(s) to quit; n (%) 87 (36.6) 56 (25.2) 46 (29.7) 7.03 0.030*
Smoking partner; n (%) 100 (41.3) 81 (36.5) 54 (34.8) 2.21 0.697
Psychosocial factors
HADS-Anxietye; M (SD) 6.10 (4.06) 6.70 (4.18) 6.84 (4.14) 1.92 0.148
HADS-Depressionf; M (SD) 5.56 (4.09) 5.22 (4.10) 5.51 (4.10) 0.45 0.640
Self-efficacyg; M (SD) 2.69 (0.76) 2.75 (0.72) 2.57 (0.78) 2.24† 0.108
Intention to quith; M (SD) 7.53 (2.29) 7.50 (2.13) 7.48 (2.02) 0.02 0.980
UC usual care, TC telephone counselling, FC face-to-face counselling
aMissing data are excluded (pairwise deletion) so n < 625 for some analyses
bLow education = primary and basic vocational schools; intermediate education = secondary vocational schools and high school degrees; high
education = higher vocational school degrees, college or university degrees
cACS = acute coronary syndrome, includes unstable angina pectoris and (non) ST elevation myocardial infarction
dRange from 0 = low nicotine dependence to 10 = high nicotine dependence
eRange from 0 = low anxiety level to 21 = high anxiety level
fRange from 0 = low depression level to 21 = high depression level
gRange from 0 = low self-efficacy to 4 = high self-efficacy towards smoking abstinence
hRange from 2 = weak intention to 10 = strong intention to quit smoking
† For non-equal variances between the groups, the Brown-Forsythe statistic and p value are reported
*p < 0.05 (significantly different to referent group (usual care))
Post-hoc tests: For nicotine dependence, Tukey post-hoc tests reveal that FC differs significantly from UC. For attempts to quit over the past
12 months, χ² analysis reveals that TC and UC differ significantly from each other
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Crude quitting rates revealed that 26.9 % of the patients
in the usual care group continued to be abstinent compared
with 34.7 % in the telephone counselling and 33.1 % in the
face-to-face counselling group at 12-month follow-up, re-
spectively (χ²(2) = 3.50, p = 0.17). As depicted in Table 2,
the GLMM analysis revealed borderline significant differ-
ential effects of the interventions on continued abstinence
by SES (p = 0.09) and by intention to quit (p = 0.08) (first
model). After removing non-significant covariates the fi-
nal GLMM model yielded significant positive differential
effects for both telephone and face-to-face counselling com-
Table 2 Differential effects of the telephone and face-to-face counselling intervention on continued abstinence from smoking for patients with
a low SES and patients with a low quit intention at 12-month follow-up (intention-to-treat) (n = 604)a
First model (n = 568) Final model (n = 579)
Variables OR 95 % CI p OR 95 % CI p
Telephone counselling 3.07 [0.97,9.73] 0.057 3.10 [1.32,7.31] 0.010
Face-to-face counselling 5.61 [1.85,17.04] 0.002 5.30 [2.13,13.17] 0.000
Age 1.02 [1.02,1.04] 0.029 1.03 [1.01,1.05] 0.009
Sex (male) 0.98 [0.63,1.54] 0.994 – – –
Marital status (married) 1.19 [0.75,1.87] 0.462 – – –
SES (high education) b 1.87 [0.94,3.72] 0.075 1.87 [0.97,3.62] 0.064
Disease diagnosis
ACSc 1.36 [0.50,3.67] 0.543 – – –
Unstable angina 2.23 [0.68,7.31] 0.184 – – –
Cardiac rehabilitation 2.34 [1.56,3.52] 0.000 2.55 [1.73,3.75] 0.000
Previous admission 1.35 [0.79,2.30] 0.280 – – –
Nicotine dependence 0.92 [0.84,1.01] 0.081 0.91 [0.83,0.99] 0.026
7-day abstinence at admission 1.36 [0.88,2.08] 0.163 – – –
Previous attempt(s) to quit 1.54 [0.99,2.40] 0.056 1.68 [1.10,2.57] 0.018
Smoking partner 0.72 [0.47,1.10] 0.128 – – –
HADS-Anxiety 1.02 [0.96,1.09] 0.515 – – –
HADS-Depression 0.94 [0.88,1.01] 0.091 – – –
Self-efficacy 1.25 [0.93,1.68] 0.148 – – –
Intention to quit 1.29 [1.07,1.56] 0.009 1.43 [1.20,1.71] 0.000
Condition x SESd – F = 2.36 0.094 – F = 1.86 0.157
TC x high SES 0.54 [0.21,1.38] 0.195 0.61 [0.25,1.51] 0.284
FC x high SES 0.33 [0.12,0.91] 0.032 0.37 [0.14,0.99] 0.048
Condition x intention to quite – F = 2.47 0.083 – F = 3.32 0.037
TC x high intention to quit 0.73 [0.43,1.23] 0.234 0.66 [0.40,1.10] 0.111
FC x high intention to quit 0.53 [0.30,0.93] 0.027 0.49 [0.28,0.84] 0.010
– ICC = 0.004 0.408 – ICC = 0.008 0.413
SES socioeconomic status; TC telephone counselling; FC face-to-face counselling; ICC intraclass correlation coefficient
Five dummy variables coding time effects were entered simultaneously with all other variables, but their coefficients are not reported here (1 =
Dec 2009–Jan 2010; 2 = Feb–June 2010; 3 = July–Nov 2010; 4 = Dec 2010–Jan 2011; 5 = Feb–June 2011). The Model uses reference groups for
categorical variables [condition = usual care; time effects = Feb–June 2011; sex = female gender; SES = high education; diagnosis = non-specified
diagnosis; cardiac rehabilitation = no; previous admission = yes; 7-day abstinence at admission = no; previous quit attempt = no; smoking partner =
no]
aSample including patients lost at follow-up as smokers. Patients with missing data on predictor variables are excluded (listwise deletion) so n <
604 for the analyses; n = 21 died and were excluded
bSocioeconomic status (SES) was derived from education and categorised as primary, intermediate or tertiary education
cACS = acute coronary syndrome, includes unstable angina pectoris and (non) ST elevation myocardial infarction
dOnly two-way interactions were tested, thus the differential effects of SES and intention need to be treated separately. Combinations yield similar
results when three-way interactions are present
eFor the interactions with intention to quit, the continuous scale scores were transformed into z-scores
pared with usual care on continued abstinence for patients
with a low SES and patients with a low intention to quit, the
effect being largest for face-to-face counselling (telephone
counselling: OR = 3.10, 95 % CI 1.32–7.31, p = 0.01; face-
to-face counselling: OR = 5.30, 95 % CI 2.13–13.17, p <
0.001). For the interventions compared with usual care,
repeating the analysis to assess the nature of the differen-
tial effects (not shown in table) yielded significant odds
ratios on continued abstinence in case of a low SES and
a moderate intention to quit (telephone counselling: OR =
2.04, 95 % CI 1.10–3.81, p = 0.03; face-to-face counselling:
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OR = 2.57, 95 % CI 1.32–5.01, p = 0.01). No differential
effects of telephone and face-to-face counselling compared
with usual care on continued abstinence were found for high
SES patients and patients with a high intention to quit (tele-
phone counselling: OR = 0.82, 95 % CI 0.39–1.72, p = 0.60;
face-to-face counselling: OR = 0.46, 95 % CI 0.20–1.09,
p = 0.08). Replicating the analysis for other scenarios (low
SES, high quit intention; high SES, low quit intention; high
SES, moderate quit intention) yielded no differential inter-
vention effect either. Nonetheless, to compare the effects of
telephone versus face-to-face counselling, further GLMM
analyses were performed using telephone counselling as the
reference group. With a high SES and a high intention to
quit, results revealed no significant differential effects of
face-to-face counselling (OR = 0.56, 95 % CI 0.24–1.34;
p = 0.20) or usual care (OR = 1.22, 95 % CI 0.58–2.56,
p = 0.60) compared with telephone counselling. Repeat-
ing the analysis for low SES patients and for patients with
a low intention to quit revealed that usual care significantly
decreased the likelihood of continued abstinence compared
with telephone counselling (OR = 0.32, 95 % CI 0.14–0.76,
p = 0.01). Face-to-face counselling for these patients did
not have a significant differential effect when compared
with telephone counselling (OR = 1.71, 95 % CI 0.77–3.80;
p = 0.19). All final GLMMs revealed that age, having
received cardiac rehabilitation, and not having made any
previous attempts to quit smoking significantly increased
the likelihood of continued abstinence, whereas a higher
nicotine dependence decreased its likelihood.
Smoking abstinence rates for subgroups at 12-month
follow-up
Post-hoc χ2 tests (Table 3) analysing continued abstinence
rates for low versus high SES patients showed significantly
higher rates of quitters in the telephone and face-to-face
Table 3 Continued abstinence rates for each group specified by SES and intention to quit at 12-month follow-up (intention-to-treat)
Continued abstinence rates for low and high SES patients (n = 591)a
Low SES % CA χ² p High SES % CA χ² p
UC (n = 130) 20.0 (n = 26)b – – UC (n = 95) 37.9 (n = 36)b – –
TC (n = 130) 33.8 (n = 44)c 8.45 0.015 TC (n = 84) 36.9 (n = 31)b 1.44 0.486
FC (n = 90) 35.6 (n = 32)c – – FC (n = 62) 29.0 (n = 18)b – –
Continued abstinence rates for patients with low and high quit intentions (n = 598)a
Low intention
to quit
% CA χ² p High intention
to quitd
% CA χ² p
UC (n = 95) 13.7 (n = 13)b – – UC (n = 137) 36.5 (n = 50)b – –
TC (n = 92) 27.2 (n = 25)c 7.91 0.019 TC (n = 121) 40.5 (n = 49)b 0.93 0.627
FC (n = 68) 30.9 (n = 21)c – – FC (n = 85) 34.1 (n = 29)b – –
SES socioeconomic status; CA continued abstinence; UC usual care; TC telephone counselling; FC face-to-face counselling
aMissing data are excluded so n < 604 for some analyses; n = 21 died and were excluded
b,cPairwise analyses for each scenario: Groups with the same superscript do not differ from each other at p < 0.05, other groups do differ
dFor the purpose of the comparisons, intention to quit was dichotomised on the basis of its median score
counselling group compared with the usual care group for
low SES patients. This was not found for high SES patients.
Repeating the analysis for patients with a low intention to
quit revealed significantly more quitters in the telephone
counselling and face-to-face counselling group compared
with the usual care group, but not among patients with
a high quit intention.
Discussion
Despite efforts in optimising smoking cessation programs,
the overall percentage of continued smoking abstinence is
still disappointing in the Netherlands [4] and therefore re-
mains an ongoing challenge. This study showed that in-
tensive counselling interventions initiated upon admission
and continued for a prolonged period post-discharge result
in substantially higher long-term smoking abstinence rates
in cardiac patients at high risk of continued smoking, i. e.
with a low SES and with a low to moderate intention to
quit. The short-term effectiveness study after six months
revealed that the interventions were both overall effective
considering continued abstinence rates, and significant con-
ditional effects of the interventions were found in patients
with a lower SES [31]. Although the intervention effects
diminished after 12 months for the total sample, among low
SES patients and patients with a low intention to quit par-
ticipation in telephone counselling increased the likelihood
of smoking abstinence threefold, whereas participation in
face-to-face counselling increased this likelihood fivefold
when compared with usual care. These results are promis-
ing since previous studies showed that this particular patient
group often persists in smoking [15–20].
The effectiveness of our study is likely to evolve from
the Ask-Advise-Refer strategy, the one week post-discharge
start of the counselling, the use of motivational interviewing
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strategies, and the counselling provision by trained smok-
ing cessation professionals outside the cardiac ward. Low
SES patients and patients with a lower intention to quit may
have especially profited from face-to-face counselling be-
cause these counselling sessions had a longer duration than
the telephone sessions. One possible explanation for the
absence of effects among patients with a more favourable
profile might be that high SES patients already had high in-
tentions and generally did well in their process of quitting
smoking, thus there was limited added value of participat-
ing in telephone or face-to-face counselling. Moreover, it
could be that those patients had quit immediately after their
event without support, perhaps not requiring any interven-
tion to remain successfully abstinent, as recently shown by
Snaterse et al. [4]. As indicated by the earlier studies in
general populations of smokers [20], low SES groups prof-
ited most from high intensity face-to-face interventions.
Misrepresentation of smoking status based on self-report
was found to be 10 % which is relatively low [32]. However,
the biochemical validation test was only realised in 44 % of
all self-reported quitters which is most likely due to prac-
tical limitations in performance of the test [33]. Since it
is likely that self-reported outcomes were not completely
accurate in patients who did not undergo validation, non-
smoking status may have been overestimated. We corrected
for this by using the intention-to-treat approach which may
have yielded an underestimation of the intervention effects
compared with earlier studies [7, 8]. Another source for de-
bate is the cut-off level that we used to discriminate smok-
ers from non-smokers. As suggested previously [30, 33],
a higher cut-off than proposed by the manufacturer was
chosen due to a present risk of inaccuracy of the NicAlert®
saliva test result, the potential use of nicotine replacement
therapies, and passive exposure to tobacco smoke in the
days before the test to be able to discriminate smokers from
non-smokers more clearly.
Other study limitations became apparent. It is conceiv-
able that selection bias occurred due to baseline differences
between the three groups and due to patients who refused
to participate in the study. Accurate insight cannot be pro-
vided into this matter because data of eligible patients who
refused participation were not registered. Moreover, as re-
cent quitters participated in the study, their quitting cannot
be attributed solely to the interventions. However, since
this applied equally to the control group and the interven-
tion groups, it was still possible to assess the additional
effects of the interventions. It can also be presumed that
the telephone counsellors and ward nurses trained as face-
to-face counsellors differed in terms of previous experience
in delivering smoking cessation counselling. Since there
is evidence that interventions delivered by multiple health
care professionals of different backgrounds are susceptible
to greater variability [34], confounding might have been in-
troduced that could have contributed to the differences in
intervention effects.
Our study supports the long-term effectiveness of inten-
sive smoking cessation counselling interventions for cardiac
patients with a less favourable profile. These interventions
are particularly effective in low SES patients and patients
with weak intentions to quit smoking. Face-to-face coun-
selling revealed the greatest effects in these patients. We
found no evidence that smoking cessation counselling pro-
vided face-to-face or by telephone is beneficial for patients
with a high SES and a high intention to quit. Although
these types of intensive interventions may reduce socioe-
conomic disparities in smoking, we conclude that different
cessation approaches are required for patients differing in
their SES and their motivation to quit. Future studies need
to investigate which intervention approach is particularly
suitable for high SES patients with high intentions to quit
to improve their abstinence rates.
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